Spark Therapeutics announced that it has expanded its leadership team through the addition of two industry veterans, Joseph La Barge and Carol Greve-Philips, who have extensive track records successfully growing biotech businesses. Joseph La Barge has joined Spark as senior vice president of business administration and general counsel. Carol Greve-Philips is joining the company as senior vice president of business development and strategy.

She worked for more than 15 years at Genzyme Corporation in roles of increasing responsibility, serving most recently as the vice president of corporate development.